Description
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal resource for clinicians, basic medical scientists, graduate basic medical science students, and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
Table of Contents
Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the ClinicDebra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. KaragiannisChapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian CancerRouba Ali- Fehmi and Eman AbdulfatahChapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer?Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian CabillicChapter 4: Ovarian Tumor Microenvironment and Innate Immune RecognitionJocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. RoqueChapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian CancerSamir A. FarghalyChapter 6: Antibody-based Therapy for Ovarian CancerYousef Alharbi, Manish S. Patankar, and Rebecca J. WhelanChapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian CancerGregory LeeChapter 8: Dendritic Cell Vaccine Therapy for Ovarian CancerCaitlin Stashwick, Brian J. Czerniecki, Janos L. TanyiChapter 9: Heat Shock Protein Vaccine Therapy for Ovarian CancerHiroyuki Abe, Amane Sasada, Shigeki Tabata, Hiroaki Kawasaki, and Minako AbeChapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian CancerScott Moerdler and Xingxing ZangChapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer TherapyAnca Maria Cimpean, Andreea Adriana Jitariu, and Marius RaicaChapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian CancerMichelle N. Messmer, Colleen S. Netherby, and Scott I. AbramsChapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future DirectionsJustin M. Drerup, Curtis A. Clark, and Tyler J. Curiel
